| |
| |
|
| Insider
Information: |
Belanoff Joseph K |
| Relationship: |
Chief Executive Officer |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
348,811 |
|
|
Indirect Shares
|
2,483,107 |
|
|
| Direct
Value |
$9,710,898 |
|
|
|
Indirect Value
|
$69,129,699 |
|
|
| Total
Shares |
2,831,918 |
|
|
| Total
Value |
$78,840,597 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
Chief Executive Officer |
2022-07-06 |
348,811 |
2022-07-07 |
2,483,107 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• – – |
2022-07-06 |
4 |
D |
$26.21 |
$11,825,664 |
D/D |
(451,189) |
348,811 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive OfficerOfficer |
• • • |
2004-04-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
600,000 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• – – |
2022-07-06 |
4 |
OE |
$2.08 |
$1,664,000 |
D/D |
800,000 |
800,000 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-11-20 |
4 |
AS |
$0.86 |
$4,300 |
D/D |
(5,000) |
2,164,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2016-11-07 |
4 |
S |
$8.22 |
$4,152,547 |
D/D |
(500,000) |
2,164,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2016-11-10 |
4 |
S |
$8.90 |
$2,670,450 |
D/D |
(300,000) |
2,164,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2016-11-11 |
4 |
S |
$9.10 |
$1,820,300 |
D/D |
(200,000) |
2,164,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • – |
2018-12-12 |
4 |
S |
$19.01 |
$4,126,509 |
D/D |
(217,115) |
2,164,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-11-17 |
4 |
AS |
$0.88 |
$4,377 |
D/D |
(5,000) |
2,169,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-10-27 |
4 |
AS |
$0.81 |
$4,050 |
D/D |
(5,000) |
2,174,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-09-29 |
4 |
AS |
$0.71 |
$1,633 |
D/D |
(2,300) |
2,181,895 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-10-25 |
4 |
AS |
$0.84 |
$2,258 |
D/D |
(2,700) |
2,181,895 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-09-29 |
4 |
AS |
$0.86 |
$4,300 |
D/D |
(5,000) |
2,184,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-09-22 |
4 |
AS |
$1.04 |
$1,976 |
D/D |
(1,900) |
2,189,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-09-15 |
4 |
AS |
$1.26 |
$756 |
D/D |
(600) |
2,191,095 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-09-13 |
4 |
AS |
$1.20 |
$3,000 |
D/D |
(2,500) |
2,191,695 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-08-29 |
4 |
AS |
$1.25 |
$10,229 |
D/D |
(8,183) |
2,194,195 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-08-22 |
4 |
AS |
$3.60 |
$360 |
D/D |
(100) |
2,202,378 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-08-10 |
4 |
AS |
$4.00 |
$6,868 |
D/D |
(1,717) |
2,202,478 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-07-31 |
4 |
AS |
$3.78 |
$7,550 |
D/D |
(2,000) |
2,204,195 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-07-28 |
4 |
AS |
$3.85 |
$9,027 |
D/D |
(2,336) |
2,206,195 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-07-27 |
4 |
AS |
$4.00 |
$5,004 |
D/D |
(1,251) |
2,208,531 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-07-25 |
4 |
AS |
$4.05 |
$3,698 |
D/D |
(913) |
2,209,882 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-07-21 |
4 |
AS |
$4.15 |
$4,150 |
D/D |
(1,000) |
2,210,795 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2006-07-12 |
4 |
AS |
$4.34 |
$6,511 |
D/D |
(1,500) |
2,211,795 |
|
- |
|
117 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
